• br Because most of the miRNAs contains the

  2022-09-17

  

  Because most of the miRNAs contains the miRNA response element, it thus might function as competing endogenous RNA (ceRNA) that fi-nally releases the inhibition of miRNA on the target gene and thus upregulates the expression of the target genes. MiRanda was used to predict the AEB071 of the miRNA

• 4μ8C In addition E F was reported to promote

  2022-09-17

  

  In addition, E2F3 was reported to promote tumor growth and metas-tasis in breast cancer.19,20 Lee et al.21 reported that silencing E2F3 sup- pressed tumor growth of Her2+ breast cancer 4μ8C by restricting mitosis. E2F4 was reported to play a role in breast cancer progression, and increased nucle

• br Discussion br A study from Taiwan reviewed elderly cervical

  2022-09-17

  

  Discussion A study from Taiwan reviewed 138 elderly cervical cancer pa-tients ( 75 years of age) and 334 young patients ( score matching based on FIGO stage, histology, Lovastatin node status, and treatment methods, a cohort of 99 pairs of patients was selected for comparison. The 5-year OS r

• br these medications within the study cohort

  2022-09-16

  

   these medications within the study cohort however may have limited any observation of potential benefit such medications may offer to reduce cancer therapy related cardiotoxicity [24–26]. 5. Conclusions In breast cancer patients CAC detected co-incidentally on CT chest predicted cardiac e

• br Breast Cancer Screening Modalities

  2022-09-16

  

  Breast Cancer Screening Modalities There are different views on the screening modalities for breast cancer. In addition, guidelines differ on when to start or stop screening, benefits and harms of screening, and the issue of false-positive and false-negative findings. Although screening can sav

• br Clinical practice impact patient care changes With the

  2022-09-16

  

  Clinical practice impact/patient care changes: With the right equipment, teledermatology can offer excellent cancer detection with reduced wait times, fewer biopsies and fewer non-essential dermatology clinic visits. ACCEPTED MANUSCRIPT ABSTRACT Background. The effectiveness and value of

• br En la tabla el an lisis

  2022-09-16

  

  En la tabla 4, el análisis multivariado por regresión de Cox, observamos que el tipo de cirugía no ofrece alguna diferencia estadísticamente significativa al ser ajustada con la estadificación anatomopatológica, las complicaciones (fis-tula), disección ganglionar, edad y sexo. Discusión y concl

• br B Proliferation of gd T cells

  2022-09-16

  

  (B) Proliferation of gd T17 Pam3CSK4 in the lungs from healthy SPF mice, tumor-bearing SPF mice, and tumor-bearing GF mice was assessed by flow cytometric analysis of Ki67 expression. (C) The number and IL-17 expression of gd T cells in the lungs were analyzed 36 h after local delivery of LPS

• br Introduction br Immunotherapy has emerged

  2022-09-15

  

  1. Introduction Immunotherapy has emerged as a robust and durable treatment option for a subset of patients; however, therapeutic efficacy has been limited to tumors with high mutational burdens and T-cell infiltration [1–5]. While immune checkpoints and co-stimulatory molecules have been effectiv

• RIPA Lysis Buffer br The in vivo therapeutic e ect of combined ABT

  2022-09-15

  

  3.5. The in vivo therapeutic effect of combined ABT199 and IRIN To further confirm the in vivo cytotoxic effect of ABT263 + AXIT combination, KRAS mutant A549 flank tumor nude mice were treated with ABT199 alone, IRIN, and ABT199 + IRIN combination for Fig. 2. The combined ABT199 and IRIN inhi

• br A set of experiments suggested

  2022-09-14

  

  A set of experiments suggested that H19 inhibited apoptosis and promoted the proliferation of GC Talaporfin (Yan et al., 2017). Interestingly, lncRNA H19 is capable of generating miR-675, which is responsible for the regulation of H19 function and differentially expressed in many human tumors (Yan

• Hashimoto S et al a Serial analysis of gene

  2022-09-14

  

  Hashimoto, S., et al., 1999a. Serial analysis of gene expression in human monocyte-de-rived dendritic cells. Blood 94, 845–852. Hashimoto, S., et al., 1999b. Serial analysis of gene expression in human monocytes and macrophages. Blood 94, 837–844. Hashimoto, S.I., et al., 2000. Identification of g

• br genetic testing was performed

  2022-09-13

  

  15) genetic testing was performed (Figure 1). Clinical parameters, including age, gender, histologic diagnosis, Eastern Cooperative Oncology Group performance status, and tumor anatomic location at initial presentation were obtained by review of the medical re-cords. The tumor sites were classifie

• br ECOG PS European Cooperative Oncology Group performance

  2022-09-13

  

  ECOG PS = European Cooperative Oncology Group performance status; Hb = haemoglobin; IQR = interquartile range; LDH = lactate dehydrogenase; N = number; NR = no result; PB = peripheral blood; PSA = prostate-specific antigen. b Kruskal-Wallis equality-of-populations rank test. 3.4. CTC AR-V

• br In conclusion we have developed a simple

  2022-09-08

  

  In conclusion, we have developed a simple, pragmatic, prognostic model using performance status, distant metastases and weight loss im-mediately prior to diagnosis predict for overall survival in older patients with advanced non-small cell lung cancer. Funding Source Conflicts of Interest

176 records 1/12 page Next 12345 Next 5 pages Last page